What is the treatment for exophthalmos?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Exophthalmos

The treatment of exophthalmos should be directed at the underlying cause, with thyroid eye disease (TED) being the most common etiology requiring a combination of medical management, orbital decompression surgery, and supportive measures to prevent vision-threatening complications. 1, 2

Diagnosis and Evaluation

Before initiating treatment, proper diagnosis is essential:

  • Imaging: CT scan is the initial recommended imaging modality for suspected bilateral exophthalmos, while MRI provides superior soft tissue detail for evaluating optic nerve involvement and intracranial extension 2
  • Clinical assessment: Measure exophthalmos using an exophthalmometer to document severity and monitor progression 1
  • Vision assessment: Evaluate for signs of optic neuropathy (visual acuity, color vision, visual fields, pupillary exam) 1
  • Thyroid function tests: Order thyroid function and associated immune studies (typically managed by endocrinology) 1

Treatment Algorithm

1. Immediate Management for Corneal Protection

  • Ocular lubricants: Artificial tears and ointments to combat exposure-related dryness 1
  • Punctal plugs: To increase tear retention on the ocular surface 1
  • Moisture chambers/swimming goggles: For severe exposure 3
  • Temporary tarsorrhaphy: In cases of severe corneal exposure not responding to conservative measures 3

2. Medical Management for Thyroid Eye Disease

  • Smoking cessation: Critical as smoking significantly worsens disease progression and reduces treatment effectiveness 2
  • Selenium supplementation: May reduce inflammatory symptoms in milder TED, particularly in selenium-deficient patients 1
  • Teprotumumab: A human monoclonal antibody inhibitor of IGF-IR that has demonstrated effectiveness in reducing proptosis and clinical activity of TED 1
  • Systemic steroids: For active inflammatory phase of TED

3. Surgical Management

Indications for Surgery:

  • Compressive optic neuropathy
  • Severe exposure keratopathy
  • Significant proptosis causing functional or cosmetic concerns
  • Restrictive strabismus causing diplopia

Surgical Options:

  • Orbital decompression: Removal of one or more orbital walls (floor, medial, lateral) to increase orbital volume and reduce proptosis 4

    • Typically involves removal of posterior orbital floor, zygomatic part of lateral wall, and/or medial wall 4
    • May include removal of orbital fat to further reduce volume 4
  • Strabismus surgery: For persistent diplopia after orbital decompression

    • Often requires recession of restricted muscles, particularly the inferior and medial rectus 1
    • May be combined with muscle union procedures in complex cases 1
  • Eyelid surgery: For correction of eyelid retraction

    • Involves lengthening of anterior, posterior, or mid-eyelid lamellae 3
    • Typically performed after orbital decompression and strabismus surgery

Special Considerations

  • Surgical sequence: When multiple procedures are needed, the recommended order is: orbital decompression first, followed by strabismus surgery, then eyelid surgery 1

  • Vision-threatening complications: Compressive optic neuropathy and severe corneal exposure require urgent intervention 2

  • Monitoring: Regular follow-up to assess disease activity, progression of exophthalmos, and development of complications 1

Pitfalls and Caveats

  • Strabismus risk: Orbital decompression surgery can induce or worsen strabismus, particularly when the medial wall is included 1

  • Timing of intervention: Surgery is typically deferred until the inflammatory phase has stabilized (usually 6 months of stable measurements), except in cases of vision-threatening complications 1

  • Non-thyroid causes: While TED is the most common cause (80% of bilateral cases), other etiologies such as orbital tumors, vascular malformations, sarcoidosis, and vasculitis must be considered, especially in unilateral cases 2

  • Superior rectus involvement: Special attention should be paid to superior rectus muscle enlargement, as it may produce reduced venous outflow from the orbit, thereby expanding orbital fat volume and worsening proptosis 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bilateral Exophthalmos

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Correction of lid retraction and exophthalmos.

Developments in ophthalmology, 2008

Research

Surgical treatment of thyrotoxic exophthalmos.

Plastic and reconstructive surgery, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.